This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
September 16-18, 2025
Hynes Convention CenterBoston, MA

Brian Laskowski
VP, Head of Quality Assurance CMC at Beacon Therapeutics
Speaker

Profile

Mr. Laskowski is currently serving as Vice President, Head of Quality Assurance CMC for Beacon Therapeutics. In his current role, he provides GMP oversight for Beacon’s late-stage clinical manufacturing and testing operations. Most recently, Brian served as Vice President of Quality for Advanced Medicine Partners and Jaguar Gene Therapy helping to advance early-stage clinical programs and developing fit for purpose quality systems. Prior to his time in the cell and gene therapy field, Brian held senior level Quality and Operations roles with ICU Medical, Pfizer, Hospira and Abbott Laboratories. Key experiences and accomplishments in these roles included: managing through rapid growth and downsizing, leading organizations through spin-offs and acquisitions (company acquiring and the company being acquired), developing and executing compliance remediation plans, and exiting FDA Warning Letters. Brian earned his Bachelor of Science degree in Chemical Engineering from the University of Illinois.

Agenda Sessions

  • Panel Discussion: Starting with the End in Mind: Designing Smart for Successful Cell & Gene Therapy Development

    9:00am